EpiPaws provides epigenetic testing services to accurately estimate the biological age of dogs and cats using cheek swab DNA samples. The service delivers an estimated age and life-stage insights to help pet owners proactively manage their animal's health. This testing allows for the establishment of a health baseline and tracking of progress over time.
Funding
$30K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
FTFounders
Product
Problem
Determining the precise age of dogs and cats, especially in rescue animals, is challenging using traditional methods. Inaccurate age estimations can hinder appropriate healthcare decisions and proactive wellness planning tailored to specific life stages.
Solution
EpiPaws offers a pet age test that utilizes epigenetic sequencing to estimate a dog or cat's age within one year of accuracy. Pet owners collect a DNA sample using a simple mouth swab and mail it back for analysis. The company's technology analyzes epigenetic markers to provide an estimated birthday and insights into the pet's life stage. This information enables owners and veterinarians to make informed decisions regarding preventative care, nutrition, and overall health management.
Target Audience
EpiPaws targets pet owners, particularly those with rescue animals, veterinarians, and shelters looking for accurate age assessments to improve pet healthcare.
Features
- Epigenetic sequencing technology for accurate age estimation
- Non-invasive sample collection via mouth swab
- Results provided within 4-6 weeks
- Estimated birthday and life-stage insights included in the report